SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Africa and its Issues- Why Have We Ignored Africa?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: epicure who wrote (52)4/28/2003 9:46:54 AM
From: epicure   of 1267
 
some REALLY good news:

Pharmaceutical giant cuts AIDS drug price in developing world
Staff Reporter
LONDON, 28 April 2003
The world's largest maker of HIV/AIDS drugs has almost halved the price of its Combivir medicine in developing countries.

LONDON: GlaxoSmithKline said Sunday the treatment will now cost 90 cents a day per patient, compared to the previous price of US$1.70.

Combivir is a combination of two HIV/AIDS drugs, AZT and 3-TC, and is widely used.

The British-based Glaxo says it was able to cut the drug's price because of improvements in manufacturing techniques that allowed it to make the drug at a lower cost.

Drug companies have come under intense pressure to lower the cost of HIV/AIDS drugs so patients in poor countries can get them.

The AIDS pandemic has claimed more than three million lives worldwide. More than 40 million people, most of them in Africa, are estimated to be living with AIDS or HIV, the virus that causes the disease.

Reuters news service quotes the head of an anti-AIDS advocacy group, Richard Feacham, saying the price cut by GlaxoSmithKline is another step towards expanding access of drugs to millions of people who need them, but more needs to be done to increase resources to help people purchase them.

Some information for this report provided by Reuters.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News